Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3230 | 2032 | 36.8 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
110 | 3 | PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER | 71389 |
617 | 2 | ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA | 13940 |
3230 | 1 | PALIPERIDONE PALMITATE//LONG ACTING INJECTABLE//LONG ACTING INJECTION | 2032 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PALIPERIDONE PALMITATE | authKW | 743728 | 3% | 75% | 66 |
2 | LONG ACTING INJECTABLE | authKW | 629926 | 3% | 79% | 53 |
3 | LONG ACTING INJECTION | authKW | 394463 | 2% | 69% | 38 |
4 | LONG ACTING RISPERIDONE | authKW | 366320 | 2% | 76% | 32 |
5 | LONG ACTING INJECTABLE ANTIPSYCHOTICS | authKW | 322153 | 1% | 79% | 27 |
6 | DEPOT | authKW | 311826 | 2% | 43% | 48 |
7 | SCHIZOPHRENIA | authKW | 268609 | 39% | 2% | 784 |
8 | RISPERIDONE LONG ACTING INJECTION | authKW | 240400 | 1% | 80% | 20 |
9 | OLANZAPINE PAMOATE | authKW | 225382 | 1% | 100% | 15 |
10 | ANTIPSYCHOTICS | authKW | 192641 | 12% | 5% | 247 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 95517 | 77% | 0% | 1566 |
2 | Health Policy & Services | 3093 | 7% | 0% | 135 |
3 | Psychology, Clinical | 2351 | 8% | 0% | 163 |
4 | Pharmacology & Pharmacy | 2291 | 21% | 0% | 435 |
5 | Clinical Neurology | 1455 | 13% | 0% | 263 |
6 | Nursing | 1227 | 5% | 0% | 97 |
7 | Health Care Sciences & Services | 505 | 4% | 0% | 77 |
8 | Medicine, General & Internal | 353 | 8% | 0% | 157 |
9 | Neurosciences | 212 | 9% | 0% | 174 |
10 | Public, Environmental & Occupational Health | 196 | 5% | 0% | 110 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GLOBAL CLIN OPERAT EMEA MAO | 60102 | 0% | 100% | 4 |
2 | MED AFFAIRS EMEA | 43300 | 0% | 41% | 7 |
3 | BIOMETR REPORTING | 41603 | 0% | 46% | 6 |
4 | IZOPHRENIA SERV | 34143 | 0% | 45% | 5 |
5 | MANHATTAN PSYCHIAT | 31297 | 0% | 42% | 5 |
6 | EMERGING MARKETS BUSINESS UNIT NEUROSCI | 30051 | 0% | 100% | 2 |
7 | HOBART MENZIES TASMANIA | 30051 | 0% | 100% | 2 |
8 | PENINSULA HLTH PSYCHIAT SERV | 30051 | 0% | 100% | 2 |
9 | PSYCHIATCLIN IZOPHRENIA PROGRAM | 30051 | 0% | 100% | 2 |
10 | PSYCHIAT | 28032 | 30% | 0% | 612 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL PSYCHIATRY | 31998 | 6% | 2% | 123 |
2 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 30384 | 3% | 3% | 61 |
3 | SCHIZOPHRENIA BULLETIN | 21607 | 3% | 2% | 64 |
4 | SCHIZOPHRENIA RESEARCH | 18495 | 4% | 1% | 85 |
5 | BMC PSYCHIATRY | 17441 | 3% | 2% | 54 |
6 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | 16570 | 2% | 3% | 41 |
7 | PSYCHIATRIC SERVICES | 13627 | 3% | 1% | 61 |
8 | INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 13454 | 1% | 3% | 27 |
9 | ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 13147 | 2% | 2% | 45 |
10 | INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING | 11246 | 1% | 3% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PALIPERIDONE PALMITATE | 743728 | 3% | 75% | 66 | Search PALIPERIDONE+PALMITATE | Search PALIPERIDONE+PALMITATE |
2 | LONG ACTING INJECTABLE | 629926 | 3% | 79% | 53 | Search LONG+ACTING+INJECTABLE | Search LONG+ACTING+INJECTABLE |
3 | LONG ACTING INJECTION | 394463 | 2% | 69% | 38 | Search LONG+ACTING+INJECTION | Search LONG+ACTING+INJECTION |
4 | LONG ACTING RISPERIDONE | 366320 | 2% | 76% | 32 | Search LONG+ACTING+RISPERIDONE | Search LONG+ACTING+RISPERIDONE |
5 | LONG ACTING INJECTABLE ANTIPSYCHOTICS | 322153 | 1% | 79% | 27 | Search LONG+ACTING+INJECTABLE+ANTIPSYCHOTICS | Search LONG+ACTING+INJECTABLE+ANTIPSYCHOTICS |
6 | DEPOT | 311826 | 2% | 43% | 48 | Search DEPOT | Search DEPOT |
7 | SCHIZOPHRENIA | 268609 | 39% | 2% | 784 | Search SCHIZOPHRENIA | Search SCHIZOPHRENIA |
8 | RISPERIDONE LONG ACTING INJECTION | 240400 | 1% | 80% | 20 | Search RISPERIDONE+LONG+ACTING+INJECTION | Search RISPERIDONE+LONG+ACTING+INJECTION |
9 | OLANZAPINE PAMOATE | 225382 | 1% | 100% | 15 | Search OLANZAPINE+PAMOATE | Search OLANZAPINE+PAMOATE |
10 | ANTIPSYCHOTICS | 192641 | 12% | 5% | 247 | Search ANTIPSYCHOTICS | Search ANTIPSYCHOTICS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OLIVARES, JM , PINAL, B , CINOS, C , (2011) COMPARISON OF LONG-ACTING ANTIPSYCHOTIC INJECTION AND ORAL ANTIPSYCHOTICS IN SCHIZOPHRENIA.NEUROPSYCHIATRY. VOL. 1. ISSUE 3. P. 275-289 | 91 | 84% | 4 |
2 | PARELLADA, E , BIOQUE, M , (2016) BARRIERS TO THE USE OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN THE MANAGEMENT OF SCHIZOPHRENIA.CNS DRUGS. VOL. 30. ISSUE 8. P. 689 -701 | 76 | 89% | 0 |
3 | AGID, O , FOUSSIAS, G , REMINGTON, G , (2010) LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA: THEIR ROLE IN RELAPSE PREVENTION.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 11. ISSUE 14. P. 2301-2317 | 97 | 67% | 27 |
4 | MONTEMAGNI, C , FRIERI, T , ROCCA, P , (2016) SECOND-GENERATION LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA: PATIENT FUNCTIONING AND QUALITY OF LIFE.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 12. ISSUE . P. 917 -929 | 73 | 78% | 0 |
5 | DE HERT, M , SERMON, J , GEERTS, P , VANSTEELANDT, K , PEUSKENS, J , DETRAUX, J , (2015) THE USE OF CONTINUOUS TREATMENT VERSUS PLACEBO OR INTERMITTENT TREATMENT STRATEGIES IN STABILIZED PATIENTS WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS WITH FIRST- AND SECOND-GENERATION ANTIPSYCHOTICS.CNS DRUGS. VOL. 29. ISSUE 8. P. 637 -658 | 88 | 63% | 2 |
6 | SUZUKI, T , (2016) A FURTHER CONSIDERATION ON LONG-ACTING INJECTABLE VERSUS ORAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA: A NARRATIVE REVIEW AND CRITICAL APPRAISAL.EXPERT OPINION ON DRUG DELIVERY. VOL. 13. ISSUE 2. P. 253 -264 | 61 | 79% | 2 |
7 | CORRELL, CU , CITROME, L , HADDAD, PM , LAURIELLO, J , OLFSON, M , CALLOWAY, SM , KANE, JM , (2016) THE USE OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA: EVALUATING THE EVIDENCE.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 77. ISSUE . P. 3 -+ | 70 | 80% | 0 |
8 | KAPLAN, G , CASOY, J , ZUMMO, J , (2013) IMPACT OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS ON MEDICATION ADHERENCE AND CLINICAL, FUNCTIONAL, AND ECONOMIC OUTCOMES OF SCHIZOPHRENIA.PATIENT PREFERENCE AND ADHERENCE. VOL. 7. ISSUE . P. 1171-1180 | 59 | 84% | 18 |
9 | RAUCH, AS , FLEISCHHACKER, W , (2013) LONG-ACTING INJECTABLE FORMULATIONS OF NEW-GENERATION ANTIPSYCHOTICS: A REVIEW FROM A CLINICAL PERSPECTIVE.CNS DRUGS. VOL. 27. ISSUE 8. P. 637-652 | 64 | 74% | 20 |
10 | CHONG, HY , TEOH, SL , WU, DBC , KOTIRUM, S , CHIOU, CF , CHAIYAKUNAPRUK, N , (2016) GLOBAL ECONOMIC BURDEN OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 12. ISSUE . P. 357 -373 | 46 | 77% | 5 |
Classes with closest relation at Level 1 |